Cargando…

Prognostic value of claudin 18.2 expression in gastric adenocarcinoma

BACKGROUND: Claudin 18.2 (CLDN18.2) is a cell surface protein expressed by gastric cancer cells. The monoclonal antibody zolbetuximab binds CLDN18.2-positive cancer cells and causes cancer cell death. A few studies researched the prognostic effect of CLDN18.2 expression in metastatic gastric adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kayikcioglu, Erkan, Yüceer, Ramazan Oğuz, Cetin, Bulent, Yüceer, Kamuran, Karahan, Nermin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994048/ https://www.ncbi.nlm.nih.gov/pubmed/36908327 http://dx.doi.org/10.4251/wjgo.v15.i2.343

Ejemplares similares

The role of claudin 18.2 and HER-2 in pancreatic cancer outcomes
por: Kayikcioglu, Erkan, et al.
Publicado: (2023)

Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
por: Arnold, A., et al.
Publicado: (2020)

Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas
por: Klempner, S.J., et al.
Publicado: (2023)

Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
por: Kim, Hyung-Don, et al.
Publicado: (2023)

Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma
por: Rohde, Christoph, et al.
Publicado: (2019)

Evaluation and reflection on claudin 18.2 targeting therapy in advanced gastric cancer
por: Zhang, Jianwei, et al.
Publicado: (2020)

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
por: Xu, Bo, et al.
Publicado: (2022)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
por: Wang, Xi, et al.
Publicado: (2022)

Prognostic value of 11-factor modified frailty index in postoperative adverse outcomes of elderly gastric cancer patients in China
por: Xu, Zi-Yao, et al.
Publicado: (2023)

Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
por: Singh, Prabhsimranjot, et al.
Publicado: (2017)

Clinicopathologic Relevance of Claudin 18.2 Expression in Gastric Cancer: A Meta-Analysis
por: Ungureanu, Bogdan Silviu, et al.
Publicado: (2021)

Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies
por: Moentenich, Valeska, et al.
Publicado: (2020)

Prognostic value of glycated hemoglobin in colorectal cancer
por: Ferroni, Patrizia, et al.
Publicado: (2016)

Preoperative albumin level is a marker of alveolar echinococcosis recurrence after hepatectomy
por: Joliat, Gaëtan-Romain, et al.
Publicado: (2017)

Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
por: Scheer, René, et al.
Publicado: (2017)

ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
por: Klempner, Samuel J., et al.
Publicado: (2023)

Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

Comparison of clinicopathological characteristics and survival outcomes between gallbladder mucinous adenocarcinoma and gallbladder adenocarcinoma: A propensity score-matched study
por: Yang, Wen-Wei, et al.
Publicado: (2023)

Gastric intestinal metaplasia is associated with gastric dysplasia but is inversely correlated with esophageal dysplasia
por: Gomez, Justin M, et al.
Publicado: (2017)

Current state and clinical outcome in Turkish patients with hepatocellular carcinoma
por: Ekinci, Omer, et al.
Publicado: (2018)

Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer
por: Zhai, Zhao, et al.
Publicado: (2020)

Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2017)

Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer
por: Kubota, Y., et al.
Publicado: (2023)

Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease
por: Yoon, Jiyoung, et al.
Publicado: (2021)

Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease
por: Kristo, Ivan, et al.
Publicado: (2017)

Prognostic factors of minimally invasive surgery for gastric cancer: Does robotic gastrectomy bring oncological benefit?
por: Nakauchi, Masaya, et al.
Publicado: (2021)

Increased 5-hydroxymethylcytosine is a favorable prognostic factor of Helicobacter pylori-negative gastric cancer patients
por: Fu, Ying-Li, et al.
Publicado: (2022)

Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade
por: Grotz, Travis Edward, et al.
Publicado: (2017)

Computed tomography perfusion imaging evaluation of angiogenesis in patients with pancreatic adenocarcinoma
por: Liu, Wen, et al.
Publicado: (2022)

Critical prognostic value of the log odds of negative lymph nodes/tumor size in rectal cancer patients
por: Xie, Jie-Bin, et al.
Publicado: (2021)

Gastric peritoneal carcinomatosis - a retrospective review
por: Tan, Hwee Leong, et al.
Publicado: (2017)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
por: Cao, Weijie, et al.
Publicado: (2022)

Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
por: Bähr-Mahmud, Hayat, et al.
Publicado: (2023)

Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value
por: Ahn, Hong-Min, et al.
Publicado: (2023)

Gastric cancer incidence based on endoscopic Kyoto classification of gastritis
por: Toyoshima, Osamu, et al.
Publicado: (2023)

Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma
por: Söderström, Henna K, et al.
Publicado: (2019)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_alejisto2a36gu426p3r0gp5th